American Neurological Association members are the foremost experts on a full spectrum of neurologic subspecialties. ANA members are available to comment on neurological conditions, as well as the latest research and therapies.
For media inquiries, please complete the Media Inquiry Form.
The Guardian published the article “Exposure to environmental toxins may be root of rise in neurological disorders” featuring ANA President, Dr. Frances Jensen, which “highlights recent research efforts to fill the gaping scientific hole in understanding of the role environmental toxins – air pollution, pesticides, microplastics, forever chemicals and more – play in increasingly common diseases like dementias and […] Read More
ANA Secretary Dr. S. Thomas Carmichael is featured in the Medical News Today article “How researchers are restoring movement in people with spinal cord injuries.” Dr. Carmichael discusses a study by researchers from the NeuroRestore research center at the École polytechnique fédérale de Lausanne (EPFL) in Switzerland that identified specific neurons that, when activated, help restore a person’s ability to […] Read More
ANA member Dr. Thomas Bleck has been selected as the recipient of the 2023 ACNS Pierre Gloor Award. The award is presented annually by the American Clinical Neurophysiology Society (ACNS) for outstanding contributions to central Clinical Neurophysiology research. Congratulations to Dr. Bleck! Read More
ANA CEO Brenda Orffer was interviewed for the latest issue of Birmingham Medical News. In the article, she shares insights into pressing national issues facing academic neurologists and neuroscientists, including fostering the development of young scientists and addressing disparities in the neurological field. Read the full article Read More
College students who vaped had lower cognitive function scores than those who didn’t, and the more they vaped, the bigger the disparity, according to first-of-its-kind research being presented at the 149 th Annual Meeting of the American Neurological Association (ANA). Read full article. Read More
Artificial intelligence (AI) is poised to revolutionize the care of neurological diseases, from detecting tumors the human eye can’t see and using implantable devices to manage various conditions to crunching data from thousands of people with the same condition to guide the development of new treatments, according to neurologists and biomedical researchers speaking at the Presidential Symposium – […] Read More
The American Neurological Association (ANA), the professional organization representing the world’s top academic neurologists and neuroscientists, has announced the recipients of its 2024 scientific awards, to be presented during the 149th Annual Meeting of the ANA, which will be held September 14-17, 2024, at the Hilton Orlando in Orlando, Florida. Read full article. Read More
Starting patients with multiple sclerosis (MS) on aggressive treatment earlier may help prevent the development of paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to faster decline due to the disease, suggests new research presented at the 149th Annual Meeting of the American Neurological Association (ANA). Read full article. Read More
People with rare genetic variants associated with Parkinson’s disease and other neurodegenerative disorders are at increased risk of developing amyotrophic lateral sclerosis (ALS), according to new research presented at the 149th Annual Meeting of the American Neurological Association (ANA). Read full article. Read More